ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
BAUDETTE, Minn., May 20, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the […]
Public Entities of America, LLC joins Apex Insurance Agency, LLC, part of Bridge Specialty Group, LLC
DAYTONA BEACH, Fla., May 20, 2024 (GLOBE NEWSWIRE) — Bridge Specialty Group, LLC (“Bridge Specialty”) is very pleased to welcome […]
Scorpio Tankers Inc. Announces Agreement for a $223.6 Million Prepayment under its 2023 $1.0 Billion Credit Facility
MONACO, May 20, 2024 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced today that it […]
Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints
– In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 […]
Voyageur Mineral Explorers Corp. Options Alberts Lake Project
TORONTO, May 20, 2024 (GLOBE NEWSWIRE) — Voyageur Mineral Explorers Corp. (“Voyageur” or the “Company”) (CSE: VOY) is pleased to […]
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
ADELAIDE, Australia and CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology […]
Brunswick Corporation releases 2023 Corporate Sustainability Report
METTAWA, Ill., May 20, 2024 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) released its 2023 Sustainability Report today, highlighting its […]
Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia
ANN ARBOR, Mich., May 20, 2024 (GLOBE NEWSWIRE) — Esperion (Nasdaq: ESPR) and Otsuka Pharmaceutical Co., Ltd (Otsuka) announced today […]
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer
LA JOLLA, Calif., May 20, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market […]
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
Results showed single-administration GLP-1 pancreatic gene therapy candidate reduced liver weight by 42% (p<0.01) and liver triglycerides by 67% (p<0.0001) […]
